Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Ikić, D."'
Publikováno v:
Cancer Letters. 158:99-102
Twenty-seven randomized patients with biopsy proven carcinoma of the uterine cervix were treated with human natural leucocytic interferon (HNLI) and followed up, while 30 randomized patients were followed up in the control group and were not treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fc603bf913965be8f444b93288a71f9
https://doi.org/10.1016/s0304-3835(00)00514-0
https://doi.org/10.1016/s0304-3835(00)00514-0
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 251:293-296
In a prospective non-randomized study 21 patients with lower lip squamous cell carcinoma were treated with human natural leukocyte interferon (HNLI). The response rate was measured by a size reduction of more than 25% and was 81%. A complete response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2557c89c982dacbe88a717152267d5b1
https://doi.org/10.1007/bf00181888
https://doi.org/10.1007/bf00181888
Autor:
Krolo, I., Marotti, M., Klarić-Čustović, R., Smolković, J., Babić, N., Lovrenčić-Prpić, G., Višković, K., Ikić, D., Milas, L.
Podjela upalnih promjena dojki.Prikaz kroničnih upala. Praćenje procesa dojki metodom UZV, MR, Dopler, mamografija.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::3e1a7dae979038601e0ca3933777f1ff
https://www.bib.irb.hr/123168
https://www.bib.irb.hr/123168
Autor:
Padovan If, Davor Ivanković, Šime Spaventi, Petar Nola, Ikić D, Vladimir Čajkovac, Zvonko Kusić, Daković N
Background. Melanoma, once considered a rare form of cancer, is increasing in incidence throughout the world. The prognosis of malignant melanoma is inversely related to the depth of tumor invasion. Methods. Twenty-seven patients were treated with r.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875782c8c9219023add5207b79c7fffa
https://www.bib.irb.hr/389141
https://www.bib.irb.hr/389141
Autor:
Mladen Belicza, Antica Soldo‐Belić, Nedim Pipić, Ikić D, Zvonko Kusić, Željko Ferenčić, Šime Spaventi, Vladimir Čajkovac, Ivo Padovan, Daković N, Teodora Gregurek‐Novak
Publikováno v:
International journal of dermatology. 34(1)
Background.Interferon is considered to be an important curative agent for dermatologic diseases. We report the follow-up experience of patients with basal cell or squamous cell carcinomas treated with human natural leukocyte interferon (hnli). Result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cabb9c359cb52dcf2657f8cb4a82f0d6
https://pubmed.ncbi.nlm.nih.gov/7896491
https://pubmed.ncbi.nlm.nih.gov/7896491
Publikováno v:
International journal of dermatology. 30(10)
Human natural leukocytic interferon (HNLI) and recombinant interferon (rIFN) alpha 2c can be used in the therapy of basal cell carcinoma. Seventy-two patients were treated for 3 to 6 weeks with a single dose of 400,000 to 1,200,000 units (HNLI) and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::526e47938088f8fd2b98608e598bb65e
https://pubmed.ncbi.nlm.nih.gov/1955231
https://pubmed.ncbi.nlm.nih.gov/1955231
Publikováno v:
International journal of dermatology. 30(1)
Human natural leukocytic interferon and recombinant HulFN alpha 2c can be used in the therapy of squamous cell carcinoma. The duration of treatment was 3-6 weeks. A single dose was 400,000-5,000,000 units given weekly for 3-6 weeks. Clinically and hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4397ff326fb4c4c061e390905ed6dd2d
https://pubmed.ncbi.nlm.nih.gov/1993569
https://pubmed.ncbi.nlm.nih.gov/1993569
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Cancer Research & Clinical Oncology; 1981, Vol. 101 Issue 3, p303-308, 6p
Autor:
Maričić, Ž., Nola, P., Ikić, D., Smudj, K., Orešić, V., Knežević, M., Rode, B., Jušić, D., Šooš, E.
Publikováno v:
Journal of Cancer Research & Clinical Oncology; 1981, Vol. 101 Issue 3, p317-323, 7p